Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8986972 Nucleic acid encoding DLL3 antibodies

Patent 8986972 was granted and assigned to Stem CentRx, Inc. on March, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8986972

Patent Inventor Names

David Liu0

Orit Foord0

Robert A. Stull0

Scott J. Dylla0

Hui Shao0

Laura Saunders0

Michael Torgov0

Date of Patent

March 24, 2015

Patent Application Number

14466939

Date Filed

August 22, 2014

Patent Citations Received

‌

US Patent 12084518 Trispecific binding proteins and methods of use

‌

US Patent 11976125 B cell maturation antigen binding proteins

Patent Primary Examiner

‌

Christine J. Saoud

Patent abstract

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8986972 Nucleic acid encoding DLL3 antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API